Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002568046 | SCV003443365 | uncertain significance | not provided | 2022-05-19 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 72 of the NFS1 protein (p.Arg72Gln). This variant is present in population databases (rs200592030, gnomAD 0.01%). This missense change has been observed in individual(s) with infantile mitochondrial complex II/III deficiency (PMID: 24498631, 33457206). ClinVar contains an entry for this variant (Variation ID: 1171019). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001523893 | SCV003815895 | uncertain significance | Combined oxidative phosphorylation deficiency 52 | 2022-01-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV001523893 | SCV001733627 | pathogenic | Combined oxidative phosphorylation deficiency 52 | 2021-06-16 | no assertion criteria provided | literature only |